Hydrocortisone manufacturers face record £130m fine as appeal rejected
The Competition Appeal Tribunal (CAT) has upheld findings by the Competition and Markets Authority (CMA) against manufacturers in a hydrocortisone price hike case.
The CAT judgement has levied fines worth “almost £130 million”, as it “unanimously upheld” the CMA’s findings against the manufacturers for “abuse of dominance”, the